bio:cap is the new international INVESTIVAL for innovators and investors in life sciences and AI - where bold ideas meet capital, industry, and policy to become reality.
From 9 - 11 June 2026 at CityCube Berlin, the city becomes a global meeting point - bridging North America and Asia. Across BioTech, TechBio, Diagnostics, and AI, bio:cap is where scientific breakthroughs, industrial innovation, and public decision-making converge.
What to expect?
Hosted by Messe Berlin under the patronage of Charité – Universitätsmedizin Berlin and the Berlin Institute of Health (BIH), and supported by the Hasso Plattner Institute (HPI), bio:cap blends conference and festival into a dynamic, interdisciplinary platform for discovery, investment, and action.
Our mission: connect visionary investors and cutting-edge bio- and tech innovators with global pharma leaders and key policymakers - to fuel breakthroughs, back high-potential ventures, and shape the frameworks that turn Europe’s science into global market success.